UMB Bank n.a. Decreases Stock Holdings in Genpact Limited $G

UMB Bank n.a. trimmed its holdings in shares of Genpact Limited (NYSE:G) by 27.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,459 shares of the business services provider’s stock after selling 552 shares during the period. UMB Bank n.a.’s holdings in Genpact were worth $64,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Sumitomo Mitsui Trust Group Inc. purchased a new stake in Genpact in the first quarter valued at $115,807,000. Clark Capital Management Group Inc. purchased a new stake in shares of Genpact in the 1st quarter valued at about $64,842,000. Ameriprise Financial Inc. increased its position in Genpact by 109.8% during the first quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider’s stock worth $81,375,000 after buying an additional 845,393 shares during the period. JPMorgan Chase & Co. increased its position in Genpact by 20.9% during the first quarter. JPMorgan Chase & Co. now owns 4,111,340 shares of the business services provider’s stock worth $207,129,000 after buying an additional 710,704 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its position in Genpact by 421.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 767,386 shares of the business services provider’s stock worth $38,662,000 after buying an additional 620,201 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on G. Mizuho lifted their price objective on shares of Genpact from $48.00 to $51.00 and gave the company a “neutral” rating in a research note on Tuesday, July 1st. Needham & Company LLC lifted their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a research note on Friday, August 8th. JPMorgan Chase & Co. dropped their price target on Genpact from $55.00 to $50.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 20th. Wall Street Zen cut Genpact from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. Finally, Deutsche Bank Aktiengesellschaft began coverage on Genpact in a research report on Thursday, July 17th. They issued a “hold” rating and a $47.00 price target on the stock. Three equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $52.29.

Insider Buying and Selling

In related news, SVP Piyush Mehta sold 76,902 shares of the company’s stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $42.58, for a total value of $3,274,487.16. Following the sale, the senior vice president owned 134,880 shares in the company, valued at $5,743,190.40. This represents a 36.31% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Balkrishan Kalra sold 55,000 shares of the company’s stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total value of $2,384,800.00. Following the completion of the sale, the chief executive officer directly owned 295,246 shares in the company, valued at $12,801,866.56. This trade represents a 15.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 3.07% of the company’s stock.

Genpact Trading Down 2.1%

Shares of G stock opened at $41.81 on Friday. The business’s fifty day moving average price is $43.79 and its 200 day moving average price is $45.27. Genpact Limited has a 1-year low of $37.82 and a 1-year high of $56.76. The firm has a market capitalization of $7.29 billion, a PE ratio of 13.89, a P/E/G ratio of 1.47 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53.

Genpact (NYSE:G) last announced its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.03. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. Genpact’s quarterly revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, sell-side analysts forecast that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.6%. The ex-dividend date was Thursday, September 11th. Genpact’s dividend payout ratio is presently 22.59%.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.